| 000 | 01894 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516084501.0 | ||
| 264 | 0 | _c20120904 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1879-1913 | ||
| 024 | 7 |
_a10.1016/j.amjcard.2012.02.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLansky, Alexandra J | |
| 245 | 0 | 0 |
_aImpact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cJul 2012 |
||
| 300 |
_a21-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xmethods |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Angiography _xmethods |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aProsthesis Design |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBrar, Somjot S | |
| 700 | 1 | _aYaqub, Manejeh | |
| 700 | 1 | _aSood, Poornima | |
| 700 | 1 | _aApplegate, Robert J | |
| 700 | 1 | _aLazar, Dana | |
| 700 | 1 | _aJankovic, Ivana | |
| 700 | 1 | _aHermiller, James B | |
| 700 | 1 | _aKoo, Kai | |
| 700 | 1 | _aSudhir, Krishnankutty | |
| 700 | 1 | _aStone, Gregg W | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 110 _gno. 1 _gp. 21-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjcard.2012.02.040 _zAvailable from publisher's website |
| 999 |
_c21666926 _d21666926 |
||